Dianthus Therapeutics, Inc. (NASDAQ: DNTH) has been capturing the attention of investors with its significant potential upside and unanimous buy ratings from analysts. As a clinical-stage..
Eton Pharmaceuticals, Inc. (NASDAQ: ETON), a promising player in the healthcare sector, has caught the attention of investors with its impressive revenue growth and substantial upside..
For investors with a keen eye on the healthcare sector, Personalis, Inc. (NASDAQ: PSNL) presents a compelling opportunity, underscored by a potential upside of 30.8% based..
Semler Scientific, Inc. (SMLR), a U.S.-based provider of medical devices, is currently trading at $17.35, presenting a compelling opportunity for investors seeking high growth potential in..
Day One Biopharmaceuticals, Inc (NASDAQ: DAWN) is a compelling entity in the biotechnology sector, with its focus sharply tuned towards developing revolutionary treatments for both childhood..
Zenas BioPharma, Inc. (NASDAQ: ZBIO) is making waves in the biotechnology sector with a promising portfolio of immunology-based therapies. As a clinical-stage biopharmaceutical company, Zenas BioPharma..
Enhabit, Inc. (NASDAQ: EHAB), a prominent player in the healthcare sector, is garnering investor attention with its specialized focus on home health and hospice services in..
For investors with a keen eye on the burgeoning healthcare sector, COMPASS Pathways Plc (NASDAQ: CMPS), a trailblazer in mental health treatment innovation, presents a compelling..
Definitive Healthcare Corp. (NASDAQ: DH) is a notable player in the health information services industry, carving its niche by offering a comprehensive software-as-a-service (SaaS) healthcare commercial..
Sionna Therapeutics, Inc. (SION), a clinical-stage biopharmaceutical company focused on innovative therapies for cystic fibrosis (CF), has garnered significant attention from investors. With a market capitalization..
For investors eyeing the biotechnology sector, Cel-Sci Corporation (CVM) presents a compelling, albeit high-risk, opportunity. With a market capitalization of $37.41 million and a focus on..
Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) occupies a unique niche within the healthcare sector as a pioneering biotechnology firm dedicated to developing gene therapies for rare and..
Castle Biosciences, Inc. (NASDAQ: CSTL), headquartered in Friendswood, Texas, is a pioneering molecular diagnostics company that has carved a niche in the healthcare sector with its..
Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) stands out in the biotechnology sector, capturing investor interest with a potential upside of 61.91%. As a clinical-stage pharmaceutical company, Amylyx..
AxoGen, Inc. (NASDAQ: AXGN) is a key player in the healthcare sector, focusing on the development and commercialization of innovative technologies for peripheral nerve regeneration and..
SI-BONE, Inc. (NASDAQ: SIBN), a prominent player in the healthcare sector specializing in medical devices, is drawing investor interest with its innovative solutions addressing musculoskeletal disorders...
Praxis Precision Medicines, Inc. (NASDAQ: PRAX) is a promising name in the biotechnology sector, focusing on therapies for central nervous system disorders. This Boston-based clinical-stage biopharmaceutical..
For investors seeking opportunities in the ever-evolving healthcare sector, Geron Corporation (NASDAQ: GERN) presents an intriguing proposition. As a biotechnology company focused on oncology therapeutics, Geron..
Arbutus Biopharma Corporation (NASDAQ: ABUS), a clinical-stage biopharmaceutical company, is attracting attention within the biotechnology sector, primarily due to its innovative pipeline and substantial market potential...
In the dynamic world of biotechnology, Trevi Therapeutics, Inc. (NASDAQ: TRVI) is gaining attention from investors with its ambitious clinical trials and promising market outlook. Specializing..












